Provider self-efficacy: rate your ability to do each of the following |
Provide primary care for pediatric patients with SCD |
Provide primary care for adult patients with SCD |
Manage acute pain in pediatric patients with SCD |
Manage acute pain in adult patients with SCD |
Manage chronic pain in pediatric patients with SCD |
Manage chronic pain in adult patients with SCD |
Identify suitable candidates for disease modifying therapies, such as hydroxyurea |
Prescribe disease modifying therapies, such as hydroxyurea |
Serve as a provider for SCD patients |
Provider benefits: provide your assessment for each of the following |
Through the STORM TeleECHO telehealth clinics, I am learning best-practice care for SCD |
I learn with guidance from STORM TeleECHO specialists in SCD management, whose knowledge and skills I respect |
I am developing my clinical expertise through participation in STORM TeleECHO |
My participation in STORM TeleECHO benefits patients under my care |
The patients under my care receive best-practice care for SCD |
I apply what I have learned about best practices through STORM TeleECHO to all of my patients with SCD |
Provider practices: describe the current treatment patterns for your patients |
Of the patients you see with SCD, what percentage is eligible for hydroxyurea? |
Of the patients eligible, what percentage has been prescribed hydroxyurea? |
What percentage of patients is up to date with pneumococcal vaccinations, as documented in the medical record? |
What percentage of patients is on chronic transfusions (>4–6 transfusions in the past 12 months)? |